|
🐜
|
Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing
22 auth.
S. Jo,
Shipra Das,
Alan Williams,
A. Chrétien,
T. Pagliardini,
A. Le Roy,
Jorge Postigo Fernandez,
Diane Le Clerre,
B. Jahangiri,
I. Chion-Sotinel,
...
S. Rozlan,
Emilie Dessez,
A. Gouble,
M. Dusseaux,
R. Galetto,
A. Duclert,
E. Marcenaro,
R. Devillier,
D. Olive,
P. Duchateau,
L. Poirot,
J. Valton
|
6 |
2021 |
6
🐜
|
|
🐜
|
Repurposing endogenous immune pathways to tailor and control chimeric antigen receptor T cell functionality
12 auth.
M. Sachdeva,
B. Busser,
Sonal Temburni,
B. Jahangiri,
Anne‐Sophie Gautron,
Alan Maréchal,
...
A. Juillerat,
Alan Williams,
S. Depil,
P. Duchateau,
L. Poirot,
J. Valton
|
5 |
2019 |
5
🐜
|
|
🐜
|
Author Correction: Repurposing endogenous immune pathways to tailor and control chimeric antigen receptor T cell functionality
12 auth.
M. Sachdeva,
B. Busser,
Sonal Temburni,
B. Jahangiri,
Anne‐Sophie Gautron,
Alan Maréchal,
...
A. Juillerat,
Alan Williams,
S. Depil,
P. Duchateau,
L. Poirot,
J. Valton
|
1 |
2020 |
1
🐜
|
|
🐬
|
Allogeneic CAR T-cells resistant to both T- and NK-cell cytotoxicity
L. Poirot,
B. Jahangiri,
P. Duchateau,
J. Valton
|
0 |
2020 |
0
🐬
|
|
🐢
|
THE EFFECT OF NANO-MOLAR DOSE OF MEPERIDINE ON THE PREVENTION OF PRURITUS DUE TO INTRATHECAL MEPERIDINE
A. Movafegh,
O. Nabavian,
Younesian Masoud,
B. Jahangiri
|
0 |
2008 |
0
🐢
|
|
🐬
|
Interaction between JWH133-induced Antinociception and two extreme Doses of Celecoxib
Zoubin Ghahramani,
S. R. Kalaj,
M. Zarindast,
B. Jahangiri,
M. Jafari
|
0 |
2009 |
0
🐬
|
